These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9415017)

  • 21. [Intracoronary thrombolytic therapy in Kawasaki disease and the usefulness of two-dimensional echocardiography in detecting intracoronary thrombi].
    Ichinose E; Kato H; Inoue O; Hirata K; Eto Y; Yoshioka F
    J Cardiogr; 1985 Mar; 15(1):79-87. PubMed ID: 4067350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical Kawasaki syndrome: how many symptoms have to be present?
    Pfafferott C; Wirtzfeld A; Permanetter B
    Heart; 1997 Dec; 78(6):619-21. PubMed ID: 9470885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intra-coronary thrombolysis for acute myocardial infarction].
    Kimata S
    Rinsho Byori; 1990 Jul; Suppl 86():11-24. PubMed ID: 2122047
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute myocardial infarction after Kawasaki disease in an infant: treatment with coronary artery bypass grafting.
    Tsuda E; Minami N; Kobayashi J; Fukaya T; Nozaki H; Noritake K; Echigo S
    Pediatr Int; 2009 Jun; 51(3):421-4. PubMed ID: 19500286
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjunctive therapies in the cath lab. Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease.
    Chandwaney RH; Stathopoulos T; Sunew J; McPherson D; Davidson CJ
    J Invasive Cardiol; 2001 Sep; 13(9):651-3. PubMed ID: 11533505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracoronary administration of the combined fibrinolytic therapy a in patient with acute myocardial infarction and end-stage coronary heart disease - a case report].
    Dziewierz A; Dudek D; Bartuś S; Legutko J; Dubiel JS
    Kardiol Pol; 2003 Jan; 58(1):45-8. PubMed ID: 14502303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
    Santos Filho RD; Tranchesi Júnior B; Caramelli B; Barbosa V; Gebara O; de Albuquerque CP; Vinagre C; Maranhão R; Pileggi F
    Arq Bras Cardiol; 1991 Jul; 57(1):9-12. PubMed ID: 1823766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preinfarction angina.
    Kloner RA; Gibson M; Cannon C; Braunwald E
    N Engl J Med; 1996 Jul; 335(1):59-60; author reply 60-1. PubMed ID: 8637553
    [No Abstract]   [Full Text] [Related]  

  • 31. Myocardial infarction in Kawasaki disease.
    Gilbert RD; de Moor MM
    S Afr Med J; 1989 May; 75(10):494-6. PubMed ID: 2727830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kawasaki disease: new and important problems in cardiology].
    Kato H; Ichinose E
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient Q-waves in an infant with asymptomatic myocardial infarction due to Kawasaki disease.
    Akagawa D; Motoki N; Hachiya A; Akazawa Y
    Cardiol Young; 2019 Feb; 29(2):231-234. PubMed ID: 30520707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thallium--201 myocardial imaging in Kawasaki disease.
    Kato S; Ohta T; Suzuki Y; Matsuyama S
    Tokai J Exp Clin Med; 1982 Jan; 7(1):69-75. PubMed ID: 7080108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease.
    Ishii M; Ueno T; Akagi T; Baba K; Harada K; Hamaoka K; Kato H; Tsuda E; Uemura S; Saji T; Ogawa S; Echigo S; Yamaguchi T; Kato H;
    Pediatr Int; 2001 Oct; 43(5):558-62. PubMed ID: 11737728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
    Harada M; Akimoto K; Ogawa S; Kato H; Nakamura Y; Hamaoka K; Saji T; Shimizu T; Kato T
    Pediatr Int; 2013 Dec; 55(6):690-5. PubMed ID: 23919576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary thrombolytic therapy in Kawasaki disease: treatment and prevention of acute myocardial infarction.
    Kato H; Ichinose E; Inoue O; Akagi T
    Prog Clin Biol Res; 1987; 250():445-54. PubMed ID: 3423053
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous streptokinase in an infant with Kawasaki's disease complicated by acute myocardial infarction.
    Burtt DM; Pollack P; Bianco JA
    Pediatr Cardiol; 1986; 6(6):307-11. PubMed ID: 3748836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome.
    Ho YL; Chen MF; Wu CC; Chen WJ; Lee YT
    Cardiology; 1996; 87(4):354-7. PubMed ID: 8793173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.